Rocklatan® Evaluation
Completed · Phase 4
Conditions studied: Glaucoma
In brief
The objective of this study is to evaluate the IOP-lowering effect when subjects are switched from various latanoprost-based regimens to Rocklatan. Subjects will stop their IOP-lowering medical therapy regimen and dose with Rocklatan for the duration of the study (12 weeks).
Key facts
- Study ID
- NCT05283395
- Run by
- Aerie Pharmaceuticals
- People needed
- 136
- Starts
- 2022-03-28
- Expected to finish
- 2023-03-22
- Last updated by the study team
- 2024-04-03
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- North Valley Eye Medical Group — Mission Hills, California, United States
- Visionary Eye Institute — Newport Beach, California, United States
- California Eye Specialists Medical Group — Pasadena, California, United States
- North Bay Eye Associates — Petaluma, California, United States
- Shettle Eye Research — Largo, Florida, United States
- Center For Sight — Venice, Florida, United States
- Georgia Eye Partners — Atlanta, Georgia, United States
- Coastal Research Associates LLC — Roswell, Georgia, United States
- Tekwani Vision Center — St Louis, Missouri, United States
- OCLI Vision — Manhasset, New York, United States
- Mark J. Weiss, MD, Inc. — Tulsa, Oklahoma, United States
- Scott & Christie and Associates, PC — Cranberry Township, Pennsylvania, United States
- Advancing Vision Research — Goodlettsville, Tennessee, United States
- VRF Eye Specialty Group — Memphis, Tennessee, United States
- Total Eye Care, PA — Memphis, Tennessee, United States
- Keystone Research — Austin, Texas, United States
- Louis M. Alpern, M.D., M.P.H., P.A — El Paso, Texas, United States
- Houston Eye Associates — Houston, Texas, United States
- Emerson Clinical Research Institute — Falls Church, Virginia, United States
- Vistar Eye Center — Roanoke, Virginia, United States
- The Eye Centers of Racine and Kenosha — Racine, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.